This book offers a holistic view of some of the key questions in M&As in the biotechnology and pharmaceutical industries whilst attempting to bridge the gap between theory and practice.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Mark Thomas is Associate Dean for Programmes and Associate Professor of Strategic and Management at ICN Business School, France. He has taught Corporate Strategy and Leadership at Master and Executive Education levels including the Advanced Master's degree in Biotechnology and Pharmaceutical Management at Grenoble EM.
He holds a PhD from Lancaster University Management School, UK. His research focuses on the change management process during post-merger integration. He also holds an MSc in Strategy and Management from Em-lyon, France and is a graduate of Harvard Business School.
Janna Rose is a professor in People, Organizations and Society at Grenoble Ecole de Management (GEM) in France. While her teaching focuses mainly on ethics and social responsibility, as well as laboratory management and innovation, she has served as a coordinator for the Chair for Public Trust in Health and a member of the ethics board (ELSI) for EIT Health projects across Europe. Previously, she worked as a technician and manager in genomics and phytochemistry laboratories before earning degrees in Medical Anthropology (MA, Tulane University) and in Ethnobotany (PhD, Florida International University).
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Books From California, Simi Valley, CA, Etats-Unis
hardcover. Etat : Fine. N° de réf. du vendeur mon0003543447
Quantité disponible : 1 disponible(s)
Vendeur : Chiron Media, Wallingford, Royaume-Uni
Hardcover. Etat : New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. N° de réf. du vendeur 6666-TNFPD-9781032157078
Quantité disponible : 5 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 46771833-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 46771833-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 46771833
Quantité disponible : Plus de 20 disponibles
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. N° de réf. du vendeur V9781032157078
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 46771833
Quantité disponible : Plus de 20 disponibles
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. N° de réf. du vendeur 398279546
Quantité disponible : 3 disponible(s)
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Covid-19 has brought so much uncertainty, but one certainty is that the vaccine race will generate winners and losers in the pharmaceutical and biotechnology industries. This will have a major impact on merger and acquisition activity. While the plethora of merger and acquisition deals are abundantly reported by the news media, there is a clear lack of in-depth analysis on the multiple rationales and various challenges in the life sciences industry. By offering contributions from a variety of experts in the biotechnology and pharmaceutical industries, as well as experts on mergers and acquisitions, this edited collection will draw upon the knowledge of a variety of different actors within the fields of pharma and biotech. This book offers a timely exploration of the complexities of mergers and acquisitions in the pharmaceutical and biotechnology industries while seeking to bridge the gap between theory and practice. It presents a critical analysis of the rationale for acquisitions and studies the challenges of ensuring a successful deal. In the light of the Covid-19 pandemic, it will also explore the impact this may have on the industry, which may further stimulate merger and acquisition activity. It will be of interest to researchers, academics, policymakers, and students in the fields of strategy, management, governance, and the biotechnology and pharmaceutical industries. 230 pp. Englisch. N° de réf. du vendeur 9781032157078
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Mark Thomas is Associate Dean for Programmes and Associate Professor of Strategic and Management at ICN Business School, France. He has taught Corporate Strategy and Leadership at Master and Executive Education levels including the Advanced Master. N° de réf. du vendeur 1161573601
Quantité disponible : Plus de 20 disponibles